Jobs / United States / Abbvie INC
Associate Director, International Market Access, Oncology
Abbvie INC · 🇺🇸 Mettawa, IL, US
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Abbvie INC paid sponsored hires in similar roles2 certified filings for “Intercontinental Market Access Director, Oncology” (Market Research Analysts and Marketing Specialists) in IL: $191k–$260k, median $225k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Abbvie INC
The US Department of Labor certified 177 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 94 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Abbvie INC →
About the role
This position supports the Director, International Market Access & Pricing (iMAP) in developing the access ambition and key deliverables like payer value propositions/stories for Venetoclax indications and ultimately providing tools and support to the market access teams in Areas and Affiliates. • This role will leverage your clinical understanding, deep global payer knowledge, and competitive insights to shape Access deliverables for Epcoritamab upcoming launches. • The position works closely with Area and affiliate personnel in determining appropriate responses/actions to developmental milestone decision points with regards to implications for local pricing and/or reimbursement issues. • The primary goal of this position is to define/refine Global pricing & access strategy, influence global commercial strategy and integrated evidence program to optimize price, reimbursement, and patient access for Venetoclax. Overall Responsibilities Include: • Addressing pricing, reimbursement, access issues across international key markets, including the EU5, CAN, JPN, AUS, and BRA. • In collaboration with the Director, International Market Access and Pricing, leverage Evidence Based Medicine expertise and clinical background, deep global payer knowledge, research and competitive insights to co-lead the Value and Access Team (VAT) through the creation of the Integerated Access Straegies • Update global access materials (IAS, value proposition, payer objection handler, negotiation pathway, etc.) based on market insights and competitor dynamics • Collaborating with other iMAP functions such as Pricing and HTA Strategy as well as GHEOR, Global Business Intelligence, Government Affairs, IMCO, MHI and complimentary Area & Affiliate Functions, to ensure solid understanding of global payer markets and emerging stakeholders in the reimbursement areas • Leading project management with regards to purchasing support, opening of POs; ensuring appropriate documentation is in place in line with company procedures and storage of pertinent documents to assigned projects Significant Work Activities -Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day) Basic Qualifications: • More than 5 years of direct biotechnology / pharmaceutical industry experience and/or payer experience • Strong interest in clinical and health economic data • Proven track record of being able to successfully interact with all levels of area, affiliate and internal authority across divisions (including Global Commercial Leaders, Forecasting, Clinical Development, HEOR, MHI, and Regulatory, as well as peer equivalents in other market access teams and the market access community as a whole). • The candidate must possess strong leadership, intrapersonal, critical thinking and analytical skills to work with a variety of groups in ensuring that the strategic direction for market access and pricing is in balance with the market as well as corporate goals. • The candidate must be sensitive to cultural and market differences as they will interact and travel to multiple countries in their role. • Relevant global payer and access experience • Education: B.A./B.S. required; Advanced degree (PharmD, MBA, PhD) in a scientific or economic area nice to have Preferred Qualifications: • Strong clinical and disease area knowledge • Experience in payer trends, evaluating drivers of market access success • Knowledge of pricing policy & regulations and healthcare in key markets • Understanding of regulatory agency requirements or policies that govern market approval, and the impact on reimbursement decisions • Knowledge of pricing regulations, pricing governance in key global markets, standard operating procedures, and the business of healthcare i